These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Enzymatic activity is necessary for thrombin-mediated increase in endothelial permeability. Aschner JL; Lennon JM; Fenton JW; Aschner M; Malik AB Am J Physiol; 1990 Oct; 259(4 Pt 1):L270-5. PubMed ID: 2221088 [TBL] [Abstract][Full Text] [Related]
4. Dissociation of antithrombotic and thrombocytopenic effects of D-phenylalanyl-L-prolyl-L-arginyl chloromethyl ketone in rabbits. Dundore RL; Clas DM; VanAller GS; Habeeb PG; Pagani ED Thromb Res; 1994 Sep; 75(6):663-6. PubMed ID: 7831686 [No Abstract] [Full Text] [Related]
5. Fibrinogen degradation product fragment D induces endothelial cell detachment by activation of cell-mediated fibrinolysis. Ge M; Tang G; Ryan TJ; Malik AB J Clin Invest; 1992 Dec; 90(6):2508-16. PubMed ID: 1281836 [TBL] [Abstract][Full Text] [Related]
6. Inhibition of Thrombin With PPACK-Nanoparticles Restores Disrupted Endothelial Barriers and Attenuates Thrombotic Risk in Experimental Atherosclerosis. Palekar RU; Jallouk AP; Myerson JW; Pan H; Wickline SA Arterioscler Thromb Vasc Biol; 2016 Mar; 36(3):446-55. PubMed ID: 26769047 [TBL] [Abstract][Full Text] [Related]
7. Nitric oxide and cGMP regulate endothelial permeability and F-actin distribution in hydrogen peroxide-treated endothelial cells. Liu SM; Sundqvist T Exp Cell Res; 1997 Aug; 235(1):238-44. PubMed ID: 9281373 [TBL] [Abstract][Full Text] [Related]
8. D-Phe-Pro-Arg-chloromethylketone: its potential use in inhibiting the formation of in vitro artifacts in blood collected during tissue-type plasminogen activator thrombolytic therapy. Mohler MA; Refino CJ; Chen SA; Chen AB; Hotchkiss AJ Thromb Haemost; 1986 Oct; 56(2):160-4. PubMed ID: 2433785 [TBL] [Abstract][Full Text] [Related]
9. Plasmin promotes an endothelium-dependent adhesion of neutrophils. Involvement of platelet activating factor and P-selectin. Montrucchio G; Lupia E; De Martino A; Silvestro L; Savu SR; Cacace G; De Filippi PG; Emanuelli G; Camussi G Circulation; 1996 Jun; 93(12):2152-60. PubMed ID: 8925584 [TBL] [Abstract][Full Text] [Related]
10. Functional characterization of a slow and tight-binding inhibitor of plasmin isolated from Russell's viper venom. Cheng AC; Tsai IH Biochim Biophys Acta; 2014 Jan; 1840(1):153-9. PubMed ID: 23999090 [TBL] [Abstract][Full Text] [Related]
12. Atriopeptin inhibition of thrombin-mediated changes in the morphology and permeability of endothelial monolayers. Baron DA; Lofton CE; Newman WH; Currie MG Proc Natl Acad Sci U S A; 1989 May; 86(9):3394-8. PubMed ID: 2524068 [TBL] [Abstract][Full Text] [Related]
13. Stimulation of heparan sulphate release from cultured endothelial cells by plasmin. Kaji T; Sakamoto M Blood Coagul Fibrinolysis; 1991 Jun; 2(3):419-23. PubMed ID: 1834236 [TBL] [Abstract][Full Text] [Related]
14. Enhancement of fibrinolytic activity of vascular endothelial cells by chaetoglobosin A, crinipellin B, geodin and triticone B. Shinohara C; Chikanishi T; Nakashima S; Hashimoto A; Hamanaka A; Endo A; Hasumi K J Antibiot (Tokyo); 2000 Mar; 53(3):262-8. PubMed ID: 10819297 [TBL] [Abstract][Full Text] [Related]
15. Plasmin-induced reduction of heparan sulfate in cultured vascular endothelial cell layer. Kaji T; Hiraga S; Fujii N; Yamamoto C; Sakamoto M; Kozuka H; Koizumi F Thromb Res; 1994 Apr; 74(2):85-93. PubMed ID: 8029819 [TBL] [Abstract][Full Text] [Related]